Showing results (21-30 of 46) with videos related to

Sort By:
Pageof 5
Alzheimer'S & Dementia (Amsterdam, Netherlands)|May 12, 2025
Disentangling the effects of sex and gender on APOE ɛ4-related neurocognitive impairmentTatiana Dessy, Amina Barhdadi, Marie-Christyne Cyr, et al.
Plos One|April 14, 2017
Methylomic changes in individuals with psychosis, prenatally exposed to endocrine disrupting compounds: Lessons from diethylstilbestrolFabrice Rivollier, Boris Chaumette, Narjes Bendjemaa, et al.
Genetic Epidemiology|January 26, 2023
Study of effect modifiers of genetically predicted CETP reductionMarc-André Legault, Amina Barhdadi, Isabel Gamache, et al.
The Journal of Continuing Education in the Health Professions|September 29, 2011
Pharmacist Web-based training program on medication use in chronic kidney disease patients: impact on knowledge, skills, and satisfactionMarie-Ève Legris, Noémie Charbonneau Séguin, Katherine Desforges, et al.
Pharmacogenomics|January 12, 2026
Clinically actionable genetic variation in patients with or at high-risk of cardiovascular diseases from the Montreal Heart InstituteMarc-Olivier Pilon, Jessica Hindi, Essaïd Oussaïd, et al.
The Pharmacogenomics Journal|January 5, 2018
Nuclear receptor gene polymorphisms and warfarin dose requirements in the Quebec Warfarin CohortPayman Shahabi, Félix Lamothe, Stéphanie Dumas, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|July 23, 2011
Development and validation of the PAIR (Pharmacotherapy Assessment in Chronic Renal Disease) criteria to assess medication safety and use issues in patients with CKDJean-François Desrochers, Jean-Philippe Lemieux, Claudia Morin-Bélanger, et al.
BMC Public Health|May 23, 2022
Time trends in social contacts before and during the COVID-19 pandemic: the CONNECT studyMélanie Drolet, Aurélie Godbout, Myrto Mondor, et al.
Pharmacogenomics|June 12, 2023
Pharmacogenomic markers of metoprolol and α-OH-metoprolol concentrations: a genome-wide association studyJean Laverdière, Maxime Meloche, Sylvie Provost, et al.
Plos One|October 11, 2016
Paternal Age Explains a Major Portion of De Novo Germline Mutation Rate Variability in Healthy IndividualsSimon L Girard, Cynthia V Bourassa, Louis-Philippe Lemieux Perreault, et al.
Pageof 5